Watchlist Price Alert

OncoCyte Corporation (OCX)

NASDAQ: OCX · Real-Time Price · USD

2.81

0.02 (0.72%)

At close: May 19, 2025, 10:31 AM

0.72% (1D)

Bid	2.76
Market Cap	80.29M
Revenue (ttm)	3.84M
Net Income (ttm)	-58.2M
EPS (ttm)	-3.79
PE Ratio (ttm)	-0.74
Forward PE	-3.03
Analyst	Buy

Ask	2.88
Volume	2,847
Avg. Volume (20D)	70,049
Open	2.94
Previous Close	2.79
Day's Range	2.81 - 2.94
52-Week Range	1.92 - 4.75
Beta	0.96

About OCX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OCX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

OncoCyte has released their quartely earnings on May 12, 2025:

Revenue of $2.32M exceeds estimates by $2.19M, with 1217.05% YoY growth.

EPS of -0.19 exceeds estimates by 0.06, with 83.19% YoY growth.

Why Price Moved

5 months ago

-0.42%

Oncocyte Corp shares are trading higher after the ... Unlock content with Pro Subscription

News

6 days ago · seekingalpha.com

OncoCyte Corporation (OCX) Q1 2025 Earnings Call Transcript

OncoCyte Corporation (NASDAQ:OCX ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Gabby Woody - Executive Assistant, HR Coordinator Josh Riggs - President & Chief Execut...

1 week ago · prismmediawire.com

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 7, 2025 – PRISM MediaWire – Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after ...

1 week ago · zacks.com

Best Momentum Stocks to Buy for May 6th

MAIA, BYRN and OCX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 6, 2025.

1 week ago · zacks.com

New Strong Buy Stocks for May 6th

MAIA, BYRN, OCX, BBVA and HMY have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2025.

3 weeks ago · zacks.com

New Strong Buy Stocks for April 24th

YARIY, OCX, SMHI, VTMX and BANF have been added to the Zacks Rank #1 (Strong Buy) List on April 24, 2025.

1 month ago · zacks.com

OncoCyte (OCX) Upgraded to Buy: What Does It Mean for the Stock?

OncoCyte (OCX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 month ago · prismmediawire.com

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

IRVINE, Calif., April 2, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Of...

1 month ago · seekingalpha.com

OncoCyte Corporation (OCX) Q4 2024 Earnings Call Transcript

OncoCyte Corporation (NASDAQ:OCX ) Q4 2024 Earnings Conference Call March 24, 2025 5:00 PM ET Company Participants Gabby Woody - Executive Assistant, HR Coordinator Josh Riggs - President and CEO Andr...

1 month ago · prismmediawire.com

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

IRVINE, Calif., March 24, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its fourth q...

2 months ago · prismmediawire.com

Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025

IRVINE, Calif., March 18, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it will report fourth quarter 2024 financial results ...